Notoginsenoside R1 attenuates atherosclerotic lesions in ApoE deficient mouse model.
AIMS: Atherosclerosis is the primary cause of cardiovascular diseases and stroke. The current study evaluated the interventional effects of a naturally occurring compound Notoginsenoside R1 (NR1) on atherosclerosis in ApoE-/- mice. METHODS AND RESULTS: The atherosclerotic lesion was significantly al...
Main Authors: | Chenglin Jia, Minqi Xiong, Peiwei Wang, Jingang Cui, Xiaoye Du, Qinbo Yang, Wenjian Wang, Yu Chen, Teng Zhang |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2014-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC4059705?pdf=render |
Similar Items
-
Notoginsenoside R1 attenuates sevoflurane-induced neurotoxicity
by: Zhang Yibing, et al.
Published: (2020-06-01) -
Candesartan attenuates hypertension-associated pathophysiological alterations in the gut
by: Dandan Wu, et al.
Published: (2019-08-01) -
Protease-Activated Receptor-2 Deficiency Attenuates Atherosclerotic Lesion Progression and Instability in Apolipoprotein E-Deficient Mice
by: Pengfei Zuo, et al.
Published: (2017-09-01) -
Notoginsenoside R1 attenuates breast cancer progression by targeting CCND2 and YBX3
by: Hai-Long Qin, et al.
Published: (2021-03-01) -
Quantification of apo[a] and apoB in human atherosclerotic lesions.
by: JM Pepin, et al.
Published: (1991-02-01)